Vigamox Ophthalmic Solution
Utilised to manage superficial ocular bacterial pathogens to support eye tissue health and target bacterial replication.
- Category
- Eye Care
- Active ingredient
- Moxifloxacin
- Route
- Ocular use
- Form
- Ophthalmic Solution
- Strengths
- 0.5% 5ml
Prescription and consultation requirements for Vigamox Ophthalmic Solution vary by destination and are determined by the fulfilment partner.
Vigamox Ophthalmic Solution details
- Condition
- Bacterial Conjunctivitis
- Alternative names
- moxifloxacin
- Therapeutic class
- Fluoroquinolone
- Pharmacological class
- Ophthalmic Antibacterial
- Contraindications
- hypersensitivity to moxifloxacin or other fluoroquinolones
- Minor side effects
- local eye discomfort; temporary blurred vision
- Moderate side effects
- conjunctival redness; dry eyes; subconjunctival haemorrhage
- Serious side effects
- severe corneal ulceration, requires immediate medical attention
- Dosage forms
- Ophthalmic Solution
- Administration route
- Ocular use
- Supply category
- Prescription-only medicine (POM)
- Manufacturer
- Alcon
- Onset Time
- 24 hours
- Duration
- 8 hours
- Storage instructions
- Store below 25°C. Do not freeze.
- Age restrictions
- Approved for infants over one year, children, and adults.
- Pregnancy and breastfeeding
- TGA Category C: Minimal systemic absorption. Safe. Breastfeeding: Compatible.
Patient summary
utilised to manage superficial ocular bacterial pathogens to support eye tissue health and target bacterial replication.
Mechanism of action
Blocks DNA gyrase and topoisomerase IV enzymes, preventing microbial transcription, repair, and cell division.